Nuheara: Receives ethics approval to begin clinical trials

Nuheara Receives ethics approval to begin clinical trials

  • Nuheara (NUH) has received ethics approval from the Australian Hearing Human Research Ethics Committee (AHHREC) to commence its medical device clinical trial
  • The company has been working to develop multi-functional, personalised, intelligent hearing devices that augment a person’s hearing
  • The company said this supports its planned expansion into clinically tested and regulatory approved medical devices
  • The company Co-founder, Managing Director and CEO Justin Miller said National Acoustics Laboratories has now commenced recruiting for company’s medical device clinical trial
  • Recruitment has already begun for the trial, which the company says supports its planned expansion into clinically tested and regulatory approved medical devices
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Cosegic Strengthens Financial Crime Expertise with Fintrail Acquisition

The acquisition enhances Cosegic's capabilities in combating financial crime.Highlights: Cosegic acquires Fintrail to enhance financial crime capabilities.The acquisition...

Keye Launches AI Co-Pilot for Private Equity Due Diligence

A game-changing tool to enhance efficiency in investment evaluations.Highlights: Keye introduces an AI-powered co-pilot for due diligence.Streamlines the...

Regulators Urged to Prioritize Gen AI Threats Over Quantum Computing Risks

Insights on the evolving regulatory landscape in fintech and AI.Highlights: Exchange Association emphasizes urgency on Gen AI regulatory...

Cryptocurrency Scam Losses Surge to $17 Billion in 2025, Fuelled by AI

Analysis reveals AI-driven schemes are escalating crypto fraud incidences.Highlights: Losses from cryptocurrency scams reached $17 billion in 2025.AI...